What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-03-26 compared with 2025-03-13 · 46 added, 39 removed, 11 unchanged (89% of the section changed)

1 unchanged sentence

Matters and Issuer Purchases of Equity Securities.

Market Information

Our common stock, par value

per share, has been publicly traded on the Nasdaq Global Market under the symbol “ACTU” since our initial public offering

(“IPO”) on August 13, 2024.

Prior to our IPO, there was no public market for our common stock.

As of February 28, 2025, there

$0.000001 per share, commenced trading on the Nasdaq Global Market under the symbol “ACTU” since our IPO on August 13, 2024.

Holders of Common Stock

As of March 17, 2026, there

were 84 holders of record of our common stock.

1 unchanged sentence

of our common stock whose shares are held in the name of various dealers, clearing agencies, banks, brokers and other fiduciaries.

We have never declared

or paid any cash dividends on our capital stock.

We intend to retain future earnings, if any, to finance the operation of our business

and do not anticipate paying any cash dividends on our capital stock in the foreseeable future.

Any future determination related to our

dividend policy will be made at the discretion of our board of directors after considering our financial condition, results of operations,

current and anticipated capital requirements, business prospects and other factors our board of directors deems relevant, and subject

to applicable laws and the restrictions contained in any future financing instruments.

We have never declared or

paid any cash dividends on our capital stock.

We intend to retain future earnings, if any, to finance the operation of our business and

do not anticipate paying any cash dividends on our capital stock in the foreseeable future.

Any future determination related to our dividend

policy will be made at the discretion of our board of directors after considering our financial condition, results of operations, current

and anticipated capital requirements, business prospects and other factors our board of directors deems relevant, and subject to applicable

laws and the restrictions contained in any future financing instruments.

Securities Authorized for Issuance Under Equity Compensation Plans

See Item 12 of Part III

of this Report for information about our equity compensation plans which is incorporated by reference herein.

The following table provides

information as of December 31, 2025 with respect to shares of common stock that may be issued under our equity compensation plans.

Plan Category

Number of Securities to be Issued Upon the Exercise of Outstanding Options, Warrants and Rights

Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights ($/share)

Number of Shares Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in column (a))

Equity compensation plans approved by stockholders

2,476,830 (1)

2,184,341 (3)

Equity compensation plans not approved by stockholders

(1) Consists of (i) options to purchase a total of 1,841,977 shares of common stock under the 2015 and 2024

Plans, (ii) 17,617 shares of our common stock that are subject to unvested RSAs under the 2015 Plan, and (iii) 617,236 shares of our common

stock that are subject to outstanding RSUs under the 2024 Plan.

(2) The weighted average exercise price is calculated based solely on outstanding stock options.

take into account the shares of our common stock subject to outstanding RSAs or RSUs, which have no exercise price.

(3) Consists of 2,184,341 shares of our common stock reserved for issuance under the 2024 Plan.

The 2024 Plan

provides for an annual increase on the first day of each calendar year beginning January 1, 2025 and ending on and including January 1,

2034, equal to the lesser of (A) 5% of the aggregate number of shares of common stock outstanding on the final day of the immediately

preceding calendar year and (B) such smaller number of shares as is determined by the administrator.

Effective January 1, 2025, the number

of shares available for grant under the 2024 Plan increased by 976,581.

The 2015 Plan terminated prior to the Company’s IPO, and

no additional awards will be granted under the 2015 Plan.

Any outstanding awards under the 2015 Plan that are subsequently cancelled,

forfeited or expire will become available for grant under the 2024 Plan.

Performance Graph

1 unchanged sentence

Recent Sales of Unregistered Securities

2024, we granted to certain of our employees (in connection with services provided to us by such persons) options to purchase 127,780

shares of our common stock with a weighted average exercise price of $4.68 under the 2015 Stock Incentive Plan (“2015 Plan”).

options and the common stock issuable upon the exercise of such options as described above were issued pursuant to written compensatory

plans or arrangements with our employees, in reliance on the exemption from the registration requirements of the Securities Act provided

by Rule 701 promulgated under the Securities Act.

All recipients either received adequate information about us or had access, through

employment or other relationships, to such information.

On August 14, 2024, we filed a registration statement on Form S-8 under the Securities

Act to register all of the shares of our common stock subject to outstanding options and all shares of our common stock otherwise issuable

pursuant to our equity compensation plans.

Use of Proceeds

August 12, 2024, our registration statement on Form S-1 (File No.

333-279734) was declared effective by the SEC for our initial public

On August 14, 2024, the Company completed the closing of its IPO of 2,800,000 shares of common stock at an initial offering

price to the public of $8.00 per share, before the underwriters discount of $0.56 per share.

Additionally, the underwriters exercised

their Overallotment Option (as defined below) to purchase an additional 420,000 shares at the same price of $8.00 per share less the underwriters

discount on September 12, 2024.

The Company received net proceeds of approximately $22 million, after deducting discounts and commissions

and other estimated offering expenses of approximately $3.7 million, in exchange for the issuance of 3,220,000 shares of common stock

of the Company, including shares issued under the Overallotment Option.

There has been no material change in the planned use of proceeds

from that described in the final prospectus for our initial public offering filed with the SEC pursuant to Rule 424(b)(4) under the Securities

Titan Partners Group LLC, a division of American Capital Partners, LLC, acted as sole bookrunner and Newbridge Securities Corporation

acted as co-manager in the offering.

the year ended December 31, 2025, we sold 539,967 shares of our common stock to B.

Riley Principal Capital II pursuant to a common stock

purchase agreement dated March 27, 2025 for the net proceeds of $3,800,465.

All shares of common stock issued and sold to B.

Riley Principal

Capital II were issued pursuant to Section 4(a)(2) of the Securities Act, as transactions not involving a public offering.

the proceeding, we did not issue any equity securities during the year ended December 31, 2025 that were not registered under the Securities

Act and that have not otherwise been described in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K.

Issuer Repurchases of Equity Securities

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity